Duaa Salih is an experienced professional in the field of pharmacovigilance and safety surveillance, currently serving as the Director of Safety Surveillance at Ionis Pharmaceuticals, Inc. since March 2023. Previously, Duaa held various roles at AstraZeneca, including Associate Director and Senior Patient Safety Scientist, where contributions focused on COVID-19 vaccine safety surveillance, signal detection, and risk management. Early roles included positions at Amicus Therapeutics as EU QPPV Operations and PV Lead, and at GSK and ViiV Healthcare as a Manager in Clinical Safety. Duaa's career began with positions at AbbVie, Orion Clinical, Roche, and PAREXEL, building a strong foundation in drug safety and risk management. Duaa graduated with a Bachelor of BioMedicine from Brunel University London in 2014.